Ainos (AIMD) had the lowest return in 2013 by a US stock in the Nasdaq Composite (IXIC), returning -95.3%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Ainos (AIMD) | 2013 | -95.35% |
Atlas Lithium Corporation Common Stock (ATLX) | 2013 | -92.7% |
Lipocine (LPCN) | 2013 | -90.41% |
Imunon (IMNN) | 2013 | -89.63% |
Vericel Corp Ord (VCEL) | 2013 | -87.67% |
Marker Therapeutics (MRKR) | 2013 | -85% |
Sobr Safe (SOBR) | 2013 | -84.47% |
Cocrystal Pharma (COCP) | 2013 | -82.93% |
Gyrodyne Company of America (GYRO) | 2013 | -82.41% |
CervoMed (CRVO) | 2013 | -82.26% |
Nixxy (NIXX) | 2013 | -80.14% |
Delcath Systems (DCTH) | 2013 | -79.32% |
Amarin (AMRN) | 2013 | -76.06% |
Aura Minerals Inc Common Shares (AUGO) | 2013 | -72.9% |
Creative Realities (CREX) | 2013 | -72.09% |
Akari Therapeutics (AKTX) | 2013 | -71.6% |
Immutep Ltd ADR (IMMP) | 2013 | -70.59% |
Perpetua Resources (PPTA) | 2013 | -70.27% |
ImmunoPrecise Antibodies (HYFT) | 2013 | -70% |
GT Biopharma (GTBP) | 2013 | -69.61% |
Anavex Life Sciences (AVXL) | 2013 | -68.35% |
SurgePays (SURG) | 2013 | -68.18% |
STRATA Skin Sciences (SSKN) | 2013 | -65.41% |
Tenax Therapeutics (TENX) | 2013 | -64.84% |
Harrow Health (HROW) | 2013 | -64.63% |
